Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Delobel

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
Plos Pathogens|September 8, 2025
Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapyNived Collercandy, Camille Vellas, Manon Nayrac, et al.
Plos One|January 28, 2014
Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaborationFaroudy Boufassa, Jérome Lechenadec, Laurence Meyer, et al.
JCI Insight|June 20, 2020
TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in womenPascal Azar, José Enrique Mejía, Claire Cenac, et al.
Ebiomedicine|December 31, 2023
Intact proviruses are enriched in the colon and associated with PD-1<sup>+</sup>TIGIT<sup>-</sup> mucosal CD4<sup>+</sup> T cells of people with HIV-1 on antiretroviral therapyCamille Vellas, Manon Nayrac, Nived Collercandy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
Gut|November 16, 2019
Hepatitis E virus replication in human intestinal cellsOlivier Marion, Sebastien Lhomme, Manon Nayrac, et al.
Infectious Diseases (London, England)|January 14, 2016
Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patientsClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohortClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2018
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)Jean-Michel Molina, Sebastien Gallien, Marie-Laure Chaix, et al.
Plos One|April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infectionPierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Plos Pathogens|September 8, 2025
Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapyNived Collercandy, Camille Vellas, Manon Nayrac, et al.
Plos One|January 28, 2014
Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaborationFaroudy Boufassa, Jérome Lechenadec, Laurence Meyer, et al.
JCI Insight|June 20, 2020
TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in womenPascal Azar, José Enrique Mejía, Claire Cenac, et al.
Ebiomedicine|December 31, 2023
Intact proviruses are enriched in the colon and associated with PD-1<sup>+</sup>TIGIT<sup>-</sup> mucosal CD4<sup>+</sup> T cells of people with HIV-1 on antiretroviral therapyCamille Vellas, Manon Nayrac, Nived Collercandy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
Gut|November 16, 2019
Hepatitis E virus replication in human intestinal cellsOlivier Marion, Sebastien Lhomme, Manon Nayrac, et al.
Infectious Diseases (London, England)|January 14, 2016
Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patientsClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohortClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2018
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)Jean-Michel Molina, Sebastien Gallien, Marie-Laure Chaix, et al.
Plos One|April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infectionPierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
Pageof 16